- Trials with a EudraCT protocol (31)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
31 result(s) found for: Wassermann test.
Displaying page 1 of 2.
EudraCT Number: 2016-000783-42 | Sponsor Protocol Number: SDX-PL/001/2016 | Start Date*: 2016-09-19 | |||||||||||
Sponsor Name:Alfa Wassermann Polska Sp. z o.o. | |||||||||||||
Full Title: A phase 3, prospective, open, pilot, monocentric study to evaluate the effect of sulodexide administered at registered dose on morphology and functional properties of the venous endothelium in pati... | |||||||||||||
Medical condition: chronic venous insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000102-35 | Sponsor Protocol Number: 35128 | Start Date*: 2014-12-19 |
Sponsor Name:Clinica Medica 5 | ||
Full Title: Effect of administration "add on" of Rifaximin on portal hypertension of patients with liver cirrhosis and esophageal varices in standard therapy with propranolol | ||
Medical condition: Portal hypertension, liver cirrhosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002628-96 | Sponsor Protocol Number: R-RID | Start Date*: 2016-09-21 |
Sponsor Name:Imperial College London | ||
Full Title: A multi-centre, double-blind, randomised, controlled clinical trial of Rifaximin to reduce infection in patients admitted to hospital with decompensated cirrhosis | ||
Medical condition: Decompensated cirrhosis - liver disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005957-23 | Sponsor Protocol Number: 142/2005/U steflux | Start Date*: 2005-12-09 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: RANDOMIZED CLINICAL STUDY OF DIFFERENT DOSES And DURATION OF PARNAPARINA In the TREATMENT Of SUPERFICIAL VENOUS THROMBOSIS - STEFLUX STUDY | |||||||||||||
Medical condition: superficial venous thromboses | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016923-77 | Sponsor Protocol Number: SULODEXIDE_VTE/01/09 | Start Date*: 2010-08-25 | |||||||||||
Sponsor Name:Alfa Wassermann SpA | |||||||||||||
Full Title: Multicentre, randomised, double blind, placebo controlled study on long-term treatment with Sulodexide for prevention of recurrent DVT in patients with venous thromboembolism | |||||||||||||
Medical condition: Venous Thromboembolism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) PL (Completed) CZ (Completed) PT (Completed) IT (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2011-003080-30 | Sponsor Protocol Number: CT2011-001 | Start Date*: 2011-07-26 | |||||||||||
Sponsor Name:ISTITUTO CLINICO HUMANITAS | |||||||||||||
Full Title: WEIGHT-ADJUSTED LOW MOLECOLAR WEIGHT HEPARIN IN RECURRENT IMPLANTATION FAILURE: A RANDOMIZED OPEN LABELED TRIAL | |||||||||||||
Medical condition: Infertile patients with at least three failed assisted reproductive tecniques | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004718-40 | Sponsor Protocol Number: MELCOM-1 | Start Date*: 2011-07-18 | |||||||||||
Sponsor Name:AISAR ASSOCIAZIONE ITALIANA PER LO STUDIO DEGLI ANTIMICROBICI E DELLE RESISTENZE | |||||||||||||
Full Title: Activities of Metronidazole + Clotrimazole in the treatment and prophylaxis of recurrent vaginal infections recurrent Candida albicans and Candida albicans spp do not. | |||||||||||||
Medical condition: women with vaginal infections by Candida albicans and non-albicans Candida spp relapsing recurrent (≥ 4 events / year) in the acute phase of the disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002821-24 | Sponsor Protocol Number: RETIC-PD/006/2011 | Start Date*: 2011-07-21 | |||||||||||
Sponsor Name:ALFA WASSERMANN | |||||||||||||
Full Title: Prospective pharmacodynamic study on patients with moderate, active Crohn’s disease treated with Rifaximin-EIR 400 mg tablets. | |||||||||||||
Medical condition: Treatment of active, moderate Crohn’s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011826-32 | Sponsor Protocol Number: RFX-VAG/002/2008 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Alfa Wassermann S.p.A. | |||||||||||||
Full Title: A phase II, multicentre, double-blind, randomised, placebo-controlled study on efficacy and tolerability of Rifaximin vaginal tablets in the treatment of bacterial vaginosis | |||||||||||||
Medical condition: Bacterial vaginosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001268-30 | Sponsor Protocol Number: ME DIV 01/05 | Start Date*: 2006-03-06 | |||||||||||
Sponsor Name:SOFAR SPA | |||||||||||||
Full Title: Not applicable | |||||||||||||
Medical condition: not applicable | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000515-80 | Sponsor Protocol Number: RIFA-AAH | Start Date*: 2012-08-29 | |||||||||||
Sponsor Name:Juan Córdoba | |||||||||||||
Full Title: Effects of rifaximin administration in patients with severe acute alcoholic hepatitis. Comparative pilot study. | |||||||||||||
Medical condition: Acute alcoholic hepatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003986-42 | Sponsor Protocol Number: Rifa1 | Start Date*: 2008-06-18 | |||||||||||
Sponsor Name:University Hospital of Tübingen | |||||||||||||
Full Title: Prospective, randomised, placebo controlled, double blind monocenter trial for the prophylactic treatment of diarrhoea with rifaximin for travellers to South- and Southeast-Asia | |||||||||||||
Medical condition: diarrhoea of travellers to South- and Southeast-Asia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002635-28 | Sponsor Protocol Number: OFT-Campos01-12 | Start Date*: 2013-04-19 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: ASSESSMENT OF THE EFFICACY OF SUBTENON NATURAL LEUCOCYTIC INTERFERON-α (IFNα) FOR THE TREATMENT OF DIABETIC MACULAR EDEMA (DME): A PILOT STUDY. | |||||||||||||
Medical condition: DIABETIC MACULAR EDEMA (DME) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000488-34 | Sponsor Protocol Number: PVTRIFA2017 | Start Date*: 2017-06-14 | |||||||||||
Sponsor Name:UMBERTO I - POLICLINICO DI ROMA | |||||||||||||
Full Title: RIFAXIMIN BLUNTED HIGHER LEVELS OF ENDOTOXIN IN CIRRHOSIS PATIENTS: A RANDOMIZED, DOUBLE BLIND, SHORT TERM INTERVENTIONAL TRIAL. | |||||||||||||
Medical condition: PATIENTS WITH CIRRHOSIS CHILD PUGH B or C Classes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002969-27 | Sponsor Protocol Number: PMF104PD1-2-3/2013 | Start Date*: 2015-12-11 | |||||||||||
Sponsor Name:Alfa Wassermann S.p.A. | |||||||||||||
Full Title: A RANDOMISED, SINGLE-BLIND, ACTIVE CONTROLLED, MULTI-CENTRE TRIAL TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, ACCEPTABILITY AND PALATABILITY OF PMF104 COMPARED TO A CONVENTIONAL PEG-ELECTROLYTE... | |||||||||||||
Medical condition: Need of bowel cleansing in order to perform a colonoscopy or any other diagnostic or therapeutic procedure concerning the colon. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) BE (Completed) FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001014-17 | Sponsor Protocol Number: RETIC/03/06 | Start Date*: 2007-07-26 | |||||||||||
Sponsor Name:Alfa Wassermann S.p.A. | |||||||||||||
Full Title: A Phase II, multicentre, double-blind, randomized, dose range finding placebo controlled study of Rifaximin- EIR tablet: clinical effectiveness and tolerability in the treatment of moderate, active... | |||||||||||||
Medical condition: Treatment of moderate, active Crohn’s disease: induction of remission. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) HU (Completed) IT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000357-41 | Sponsor Protocol Number: APC040 | Start Date*: 2013-08-28 |
Sponsor Name:The Alimentary Pharmabiotic Centre, University College Cork | ||
Full Title: Identification of the Microbiota Dependent Response to Rifaximin in Irritable Bowel Syndrome Patients | ||
Medical condition: Irritable Bowel Syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-024177-39 | Sponsor Protocol Number: RIBS-MIC/002/2010 | Start Date*: 2011-02-01 | |||||||||||
Sponsor Name:ALFA WASSERMANN | |||||||||||||
Full Title: Prospective microbiological study on patients with non-constipation IBS treated with rifaximin 550 mg tablets. | |||||||||||||
Medical condition: Non constipation Irritable Bowel Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006157-27 | Sponsor Protocol Number: DAR-01 | Start Date*: 2007-03-20 | |||||||||||
Sponsor Name:Bama-Geve S.L. | |||||||||||||
Full Title: Estudio abierto, aleatorizado, de grupos paralelos y un año de seguimiento para evaluar la eficacia y tolerabilidad de rifaximina en la prevención de recaídas de diverticulitis y en la mejoría de l... | |||||||||||||
Medical condition: Prevención de recaídas de diverticulitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011856-23 | Sponsor Protocol Number: ERNPL | Start Date*: 2009-09-16 | |||||||||||
Sponsor Name:OSPEDALE POLICLINICO S. MATTEO | |||||||||||||
Full Title: Evaluation of acute postsurgery pain management in patients who undergo inguen hernia surgery | |||||||||||||
Medical condition: Acute post surgery pain in patients who undergo inguen hernia surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
